Bromide

Bromide

SCHEMBL7484876

Br.Oc1cc2c(cc1F)CCN(Nc1ccncc1)C2

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.34
CYP3A4 P08684 3/20 0.34
CYP11B1 P15538 3/20 0.34
CYP11B2 P19099 3/20 0.34
DRD4 P21917 2/20 0.33
DRD2 P14416 1/20 0.33
DRD1 P21728 1/20 0.33
DRD5 P21918 1/20 0.33
DRD3 P35462 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ABCB1 P08183 1/20 0.31
GPR142 Q7Z601 1/20 0.30
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7489287 0.99 MEN1 (0.34) CYP17A1CYP3A4CYP11B1CYP11B2DRD4
SCHEMBL7481508 0.81 MEN1 (0.36) CYP17A1CYP3A4CYP11B1DRD4DRD2
Hydrochloric Acid SCHEMBL7482682 0.80 MEN1 (0.36) CYP17A1CYP3A4CYP11B1DRD4DRD2
SCHEMBL7476993 0.80 DRD3 (0.52) DRD4DRD2DRD1DRD5DRD3
SCHEMBL7478486 0.80 KMT2A (0.47) CYP3A4DRD4DRD3MEN1KMT2A
Hydrochloric Acid SCHEMBL7474283 0.79 DRD3 (0.51) DRD4DRD2DRD1DRD5DRD3
SCHEMBL7480264 0.79 DRD1 (0.43) CYP11B2DRD4DRD2DRD1DRD5
SCHEMBL7484532 0.76 KMT2A (0.42) DRD4DRD3MEN1KMT2A
SCHEMBL7484538 0.76 KMT2A (0.39) DRD4DRD3MEN1KMT2A
Bromide SCHEMBL7488739 0.75 CYP17A1 (0.30) CYP17A1CYP3A4CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0950056-B1 N-(PYRIDINYLAMINO)ISOINDOLINES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2002-09-18 EP disclosed
US-6004977-A ANTIDEPRESSANTS, COGNITION ACTIVATORS, AND ALZHEIMER'S DISEASE TREATMENT HOECHST MARION ROUSSEL, INC. (US) 1999-12-21 US disclosed
EP-0950056-A2 N-(PYRIDINYLAMINO)ISOINDOLINES AND RELATED COMPOUNDS HOECHST MARION ROUSSEL, INC. (US) 1999-10-20 EP disclosed
WO-1998029407-A2 N-(PYRIDINYLAMINO)ISOINDOLINES FOR TREATING ALZHEIMER'S AND DEPRESSION HOECHST MARION ROUSSEL, INC. (US) 1998-07-09 WO disclosed